We use cookies for a better user experience. Read our Privacy Policy

I Agree

T-cell Therapy Market

Global T-cell Therapy Market by Indication (Hematologic Malignancies, Solid Tumours and Other Indications), by Therapy Type (CAR T-cell Therapy, TCR-based and TIL-based), by Modality (Research and Commercialized) and Region - 2023 to 2033

Newly-released T-cell Therapy Market analysis report by Transparency Market Research reveals that the global market in 2022 was held at US$ 5.3 Billion. With a CAGR of 27.9%, the market is projected to reach a US$ 76.6 billion valuation by 2033. CAR T-cell Therapy is expected to be the highest revenue-generating segment, projected to grow at a CAGR of 28.6% from 2023 to 2033.

Revenue of the T-cell Therapy Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the T-cell Therapy Market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of T-cell Therapy increased by around 22.9% CAGR.

T-cell therapy is a type of immunotherapy that fights cancer by using specifically engineered T cells, which are part of the immune system. T cells from a patient's blood are taken and manipulated to develop specific structures on their surface known as chimeric antigen receptors. The new receptors on these T cells enable them to latch onto a specific antigen on the patient's tumor cells and destroy them when they are reinfused into the patient.

T-cell therapy is currently approved by the FDA as the standard of care for certain types of aggressive, relapsed, or refractory non-Hodgkin lymphoma, such as diffuse large B cell lymphoma, primary mediastinal B-cell lymphoma, high-grade B-cell lymphoma, transformed follicular lymphoma, and mantle cell lymphoma.

Advancements in gene therapy techniques, increased government and private investment in cancer research, growing awareness of advanced cancer treatments, an increase in the number of cancer research centers, and the development of healthcare infrastructure in developing countries are expected to drive significant growth in the global T-cell therapy market.

Which Factors are Propelling T-cell Therapy Demand?

With the approval of Yescarta, Kymriah, and Tecartus, numerous businesses have moved away from developing protein and small molecule-based medicines and toward adoptive therapy. This has prompted significant expenditures in this area by both public and commercial entities, propelling the market for T-cell therapy forward.

Advanced manufacturing capabilities and rising approvals are predicted to increase competition across Europe for T-cell therapy companies in the coming years. The European Medicines Agency, for instance, approved Kite Pharma's Tecartus, the only CAR-T treatment for mantle cell lymphoma, in December 2020.

Region-wise Analysis

Which Region is projected to Offer the Largest Opportunity for T-cell Therapy business?

North America spearheaded the T-cell therapy market in 2022, with roughly 40% of the overall market. This achievement was driven by the United States, which conducted extensive research into the treatment of T-cells and had a robust commercial infrastructure in place, with medical school programs at the forefront of the research.

Moreover, the growing number of medical approvals in the United States and Canada, plus the area's changing reimbursement framework, has compelled the designation of these medications, resulting in considerable business growth. Moreover, the location of a lot of medical clinics that provide CAR-T cell treatments facilitates market growth.

China has emerged as a prospective market for CAR-T treatments in recent years, with the most registered clinical studies for these medicines. The country's concentrated efforts on government investment and reforms have resulted in a significant development, with the fastest CAGR in the region.

Country-wise Analysis

Which Country Lies at the CenterStage for T-cell Therapy Market Revenue?

The United States is expected to have the highest market of US$ 25.9 Billion by the end of 2033. The United States continues to be an appealing prospect for businesses, as a highly trained pool of researchers, greater government funding for research, and a clear regulatory framework guarantee consistent growth for the T-cell Therapy industry.

Category-wise Insights

Why CAR T-cell Therapy segment is projected to Witness the Fastest Growth among T-cell Therapy Types?

CAR T-cell Therapy segment is forecasted to grow at the highest CAGR of over 28.6% from 2023 to 2033. This is due to the exponential increase in the number of clinical studies for CAR-T treatments, as well as the growing engagement of important companies in the field.

Several new entrants and institutions have entered into clinical studies for many CAR-T therapy products for similar and similar functions, increasing the segment's leadership.

Improved CAR-T immunotherapy has assisted in the use of numerous kinds of biological treatments for numerous types of tumors. New technologies, such as second-generation, next-generation CAR-T immunotherapy, may provide cures for issues such as resistance to medication and adverse reactions, leading to greater medical cost recovery.

On the other hand, T-cell receptor-based therapies were ranked number two worldwide for their positive impact on melanoma treatment. They are partnered with GlaxoSmithKline, with Adaptimmune being one of the firms focusing on modifiers of this technology.

Which Modality of T-cell Therapy is expected to Score Highest Growth in the Coming Years?

The research segment commanded the largest revenue as well as CAGR of nearly 29.1%, during the forecast period. Due to a large number of clinical trials in the research phase, the pharmaceutical industry led the market in T-cell therapy in 2020, accounting for more than 75% of the revenue share. A large number of medical institutes such as Mayo Clinic are involved in CAR-T therapy ventures, indicating that this technology is a viable option for cancer treatment.

Various successful corporate organizations in different fields have joined worldwide community-based pharmacies, which leads to more conversation regarding creating chimeric antigen receptor T-cell (CAR-T) treatments to expand the range of therapeutic applications. As Immuneel Therapeutics partnered with the Institut d'Investigacions Biom diques August Pi I Sunyer and the Hospital Clnic de Barcelona in October 2020, they have partnered as well to help develop and commercialize CAR-T therapies in India.

Regulatory organizations, on the other hand, are working hard to promote the commercial use of these treatments in clinical and hospital settings. The Centers for Medicare and Medicaid Services (CMS) will announce reimbursement and coverage regulations for CAR-T cell treatment in August 2020. As a result of this policy, the amount received climbed to 65 percent of the overall cost. This would increase commercial income.

Competitive Analysis

The key players in the T-Cell Therapy Market include Novartis AG, Merck KGaA, Gilead Sciences Inc., TCR2 Therapeutics Inc, Bluebird Bio Inc., Sorrento Therapeutics, Fate Therapeutics, Pfizer Inc., Amgen, and Celgene Corporation.

Few of the recent developments of key T-cell Therapy providers are as follows:

  • In November 2020, in a $359 million pharma acquisition transaction, Sanofi inked a binding agreement to buy Kiadis, a biopharmaceutical startup. Kiadis will employ its natural killer (NK) cell-based technology to research therapies for life-threatening illnesses as part of this partnership. This technology is based on NK-cells from "healthy donors," and it has the potential to make NK-cell treatment products available for a larger range of applications swiftly and affordably.
  • In October 2020, Bayer purchased Asklepios BioPharmaceutical (AskBio) to expand its cell and gene therapy portfolio. AskBio's gene therapy platform, which comprises exploratory pre-clinical and clinical stage candidates for the treatment of neuromuscular, central nervous system, cardiovascular, and metabolic illnesses, will be fully owned by Bayer as part of the agreement. Bayer will be able to treat patients in a variety of illness areas where there is a significant unmet demand.

Similarly, recent developments related to companies in the T-cell Therapy services have been tracked by the team at Transparency Market Research, which is available in the full report.

Market Segments Covered in T-cell Therapy Market Analysis

By Indication

  • Hematologic Malignancies
    • Lymphoma
    • Leukaemia
    • Myeloma
  • Solid Tumours
    • Melanoma
    • Brain & Central Nervous system
    • Liver cancer
    • Other solid Tumours
  • Other Indications

By Therapy Type

  • CAR T-cell Therapy
  • T-cell Receptor (TCR)-based
  • Tumour Infiltrating Lymphocytes (TIL)-based

By Modality

  • Research
  • Commercialized

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

T-cell Therapy Market Snapshot

Attribute

Details

Global T-Cell Therapy Market (2023)

US$ 6.6 Billion

Global T-Cell Therapy Industry (2033)

US$ 76.6 Billion

Global Market CAGR (2023 to 2033)

27.9%

U.S. T-Cell Therapy Market CAGR (2023 to 2033)

28%

Key Companies Profiled

  • Novartis AG
  • Merck KGaA
  • Gilead Sciences Inc.
  • TCR2 Therapeutics Inc
  • Bluebird Bio Inc.
  • Sorrento Therapeutics
  • Fate Therapeutics
  • Pfizer Inc.
  • Amgen
  • Celgene Corporation
T-cell Therapy Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How much is the current worth of the T-cell Therapy Market?

The global market is worth more than US$ 6.6 Billion at present.

What is the sales forecast for T-cell Therapy Market?

The market is projected to increase at a CAGR of around 27.9% from 2023 to 2033.

What was the last 5 year’s market CAGR?

The market increased at a CAGR of around 22.9% during 2018 – 2022.

What is a key trend shaping the growth of the market for T-cell Therapy?

Players in the market are constantly either acquiring smaller firms in developing and developed markets around the globe or merging with their peers to gain a strategic edge over the competitors.

At what percentage are sales of T-cell Therapy Market going to register growth in China?

The market of T-cell Therapy in China is projected to expand at a CAGR of around 33.2% from 2023 to 2033.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 27.3%, the market in Japan is projected to register a CAGR of nearly 26.7% during 2023 - 2033.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. Value Chain Analysis

        3.5.1. Profit Margin Analysis

        3.5.2. Service Providers

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global T-cell Therapy Market Analysis 2018-2022 and Forecast, 2023-2033

    4.1. Historical Market Size Value (US$ Bn) Analysis, 2018-2022

    4.2. Current and Future Market Size Value (US$ Bn) Projections, 2023-2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Bn) Analysis By Indication , 2018-2022

    5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Indication , 2023-2033

        5.3.1. Hematologic Malignancies

            5.3.1.1. Lymphoma

            5.3.1.2. Leukemia

            5.3.1.3. Myeloma

        5.3.2. Solid Tumors

            5.3.2.1. Melanoma

            5.3.2.2. Brain & Central Nervous System

            5.3.2.3. Liver Cancer

            5.3.2.4. Other Solid Tumors

        5.3.3. Other Indications

    5.4. Y-o-Y Growth Trend Analysis By Indication , 2018-2022

    5.5. Absolute $ Opportunity Analysis By Indication , 2023-2033

6. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Therapy Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Bn) Analysis By Therapy Type, 2018-2022

    6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Therapy Type, 2023-2033

        6.3.1. CAR T-cell Therapy

        6.3.2. T Cell Receptor (TCR)-based

        6.3.3. Tumor Infiltrating Lymphocytes (TIL)-based

    6.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2018-2022

    6.5. Absolute $ Opportunity Analysis By Therapy Type, 2023-2033

7. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Modality

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Bn) Analysis By Modality , 2018-2022

    7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Modality , 2023-2033

        7.3.1. Research

        7.3.2. Commercialized

    7.4. Y-o-Y Growth Trend Analysis By Modality , 2018-2022

    7.5. Absolute $ Opportunity Analysis By Modality , 2023-2033

8. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2018-2022

    8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2023-2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022

    9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Indication

        9.2.3. By Therapy Type

        9.2.4. By Modality

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Indication

        9.3.3. By Therapy Type

        9.3.4. By Modality

    9.4. Key Takeaways

10. Latin America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022

    10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Indication

        10.2.3. By Therapy Type

        10.2.4. By Modality

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Indication

        10.3.3. By Therapy Type

        10.3.4. By Modality

    10.4. Key Takeaways

11. Europe T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022

    11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. Russia

            11.2.1.7. Rest of Europe

        11.2.2. By Indication

        11.2.3. By Therapy Type

        11.2.4. By Modality

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Indication

        11.3.3. By Therapy Type

        11.3.4. By Modality

    11.4. Key Takeaways

12. Asia Pacific T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022

    12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. India

            12.2.1.4. South Korea

            12.2.1.5. Australia

            12.2.1.6. Rest of APAC

        12.2.2. By Indication

        12.2.3. By Therapy Type

        12.2.4. By Modality

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Indication

        12.3.3. By Therapy Type

        12.3.4. By Modality

    12.4. Key Takeaways

13. MEA T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022

    13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033

        13.2.1. By Country

            13.2.1.1. South Africa

            13.2.1.2. Saudi Arabia

            13.2.1.3. UAE

            13.2.1.4. Israel

            13.2.1.5. Rest of MEA

        13.2.2. By Indication

        13.2.3. By Therapy Type

        13.2.4. By Modality

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Indication

        13.3.3. By Therapy Type

        13.3.4. By Modality

    13.4. Key Takeaways

14. Key Countries T-cell Therapy Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2022

            14.1.2.1. By Indication

            14.1.2.2. By Therapy Type

            14.1.2.3. By Modality

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2022

            14.2.2.1. By Indication

            14.2.2.2. By Therapy Type

            14.2.2.3. By Modality

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2022

            14.3.2.1. By Indication

            14.3.2.2. By Therapy Type

            14.3.2.3. By Modality

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2022

            14.4.2.1. By Indication

            14.4.2.2. By Therapy Type

            14.4.2.3. By Modality

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2022

            14.5.2.1. By Indication

            14.5.2.2. By Therapy Type

            14.5.2.3. By Modality

    14.6. Italy

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2022

            14.6.2.1. By Indication

            14.6.2.2. By Therapy Type

            14.6.2.3. By Modality

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2022

            14.7.2.1. By Indication

            14.7.2.2. By Therapy Type

            14.7.2.3. By Modality

    14.8. U.K.

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2022

            14.8.2.1. By Indication

            14.8.2.2. By Therapy Type

            14.8.2.3. By Modality

    14.9. Spain

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2022

            14.9.2.1. By Indication

            14.9.2.2. By Therapy Type

            14.9.2.3. By Modality

    14.10. Russia

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2022

            14.10.2.1. By Indication

            14.10.2.2. By Therapy Type

            14.10.2.3. By Modality

    14.11. China

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2022

            14.11.2.1. By Indication

            14.11.2.2. By Therapy Type

            14.11.2.3. By Modality

    14.12. Japan

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2022

            14.12.2.1. By Indication

            14.12.2.2. By Therapy Type

            14.12.2.3. By Modality

    14.13. India

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2022

            14.13.2.1. By Indication

            14.13.2.2. By Therapy Type

            14.13.2.3. By Modality

    14.14. South Korea

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2022

            14.14.2.1. By Indication

            14.14.2.2. By Therapy Type

            14.14.2.3. By Modality

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2022

            14.15.2.1. By Indication

            14.15.2.2. By Therapy Type

            14.15.2.3. By Modality

    14.16. South Africa

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2022

            14.16.2.1. By Indication

            14.16.2.2. By Therapy Type

            14.16.2.3. By Modality

    14.17. Saudi Arabia

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2022

            14.17.2.1. By Indication

            14.17.2.2. By Therapy Type

            14.17.2.3. By Modality

    14.18. UAE

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2022

            14.18.2.1. By Indication

            14.18.2.2. By Therapy Type

            14.18.2.3. By Modality

    14.19. Israel

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2022

            14.19.2.1. By Indication

            14.19.2.2. By Therapy Type

            14.19.2.3. By Modality

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Indication

        15.3.3. By Therapy Type

        15.3.4. By Modality

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Novartis AG

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

                16.1.1.5.2. Product Strategy

                16.1.1.5.3. Channel Strategy

        16.1.2. Merck KGaA

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

                16.1.2.5.2. Product Strategy

                16.1.2.5.3. Channel Strategy

        16.1.3. Gilead Sciences Inc.

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

                16.1.3.5.2. Product Strategy

                16.1.3.5.3. Channel Strategy

        16.1.4. TCR2 Therapeutics Inc

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

                16.1.4.5.2. Product Strategy

                16.1.4.5.3. Channel Strategy

        16.1.5. Bluebird Bio Inc

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

                16.1.5.5.2. Product Strategy

                16.1.5.5.3. Channel Strategy

        16.1.6. Sorrento Therapeutics

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

                16.1.6.5.2. Product Strategy

                16.1.6.5.3. Channel Strategy

        16.1.7. Fate Therapeutics

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

                16.1.7.5.2. Product Strategy

                16.1.7.5.3. Channel Strategy

        16.1.8. Pfizer Inc

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

                16.1.8.5.2. Product Strategy

                16.1.8.5.3. Channel Strategy

        16.1.9. Amgen

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

                16.1.9.5.2. Product Strategy

                16.1.9.5.3. Channel Strategy

        16.1.10. Celgene Corporation

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

                16.1.10.5.2. Product Strategy

                16.1.10.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

List of Tables

Table 1: Global T-cell Therapy Market Value (US$ Bn) Forecast by Region, 2018-2033

Table 2: Global T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033

Table 3: Global T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033

Table 4: Global T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

Table 5: North America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 6: North America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033

Table 7: North America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033

Table 8: North America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

Table 9: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 10: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033

Table 11: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033

Table 12: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

Table 13: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 14: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033

Table 15: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033

Table 16: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

Table 17: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 18: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033

Table 19: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033

Table 20: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

Table 21: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 22: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033

Table 23: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033

Table 24: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

List of Figures

Figure 1: Global T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033

Figure 2: Global T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033

Figure 3: Global T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033

Figure 4: Global T-cell Therapy Market Value (US$ Bn) by Region, 2023-2033

Figure 5: Global T-cell Therapy Market Value (US$ Bn) Analysis by Region, 2018-2033

Figure 6: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Region, 2023-2033

Figure 7: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Region, 2023-2033

Figure 8: Global T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033

Figure 9: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033

Figure 10: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033

Figure 11: Global T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033

Figure 12: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033

Figure 13: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033

Figure 14: Global T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033

Figure 15: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033

Figure 16: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033

Figure 17: Global T-cell Therapy Market Attractiveness by Indication , 2023-2033

Figure 18: Global T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033

Figure 19: Global T-cell Therapy Market Attractiveness by Modality , 2023-2033

Figure 20: Global T-cell Therapy Market Attractiveness by Region, 2023-2033

Figure 21: North America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033

Figure 22: North America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033

Figure 23: North America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033

Figure 24: North America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033

Figure 25: North America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033

Figure 26: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 27: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 28: North America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033

Figure 29: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033

Figure 30: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033

Figure 31: North America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033

Figure 32: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033

Figure 33: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033

Figure 34: North America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033

Figure 35: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033

Figure 36: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033

Figure 37: North America T-cell Therapy Market Attractiveness by Indication , 2023-2033

Figure 38: North America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033

Figure 39: North America T-cell Therapy Market Attractiveness by Modality , 2023-2033

Figure 40: North America T-cell Therapy Market Attractiveness by Country, 2023-2033

Figure 41: Latin America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033

Figure 42: Latin America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033

Figure 43: Latin America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033

Figure 44: Latin America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033

Figure 45: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033

Figure 46: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 47: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 48: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033

Figure 49: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033

Figure 50: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033

Figure 51: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033

Figure 52: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033

Figure 53: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033

Figure 54: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033

Figure 55: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033

Figure 56: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033

Figure 57: Latin America T-cell Therapy Market Attractiveness by Indication , 2023-2033

Figure 58: Latin America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033

Figure 59: Latin America T-cell Therapy Market Attractiveness by Modality , 2023-2033

Figure 60: Latin America T-cell Therapy Market Attractiveness by Country, 2023-2033

Figure 61: Europe T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033

Figure 62: Europe T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033

Figure 63: Europe T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033

Figure 64: Europe T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033

Figure 65: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033

Figure 66: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 67: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 68: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033

Figure 69: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033

Figure 70: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033

Figure 71: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033

Figure 72: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033

Figure 73: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033

Figure 74: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033

Figure 75: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033

Figure 76: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033

Figure 77: Europe T-cell Therapy Market Attractiveness by Indication , 2023-2033

Figure 78: Europe T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033

Figure 79: Europe T-cell Therapy Market Attractiveness by Modality , 2023-2033

Figure 80: Europe T-cell Therapy Market Attractiveness by Country, 2023-2033

Figure 81: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033

Figure 82: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033

Figure 83: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033

Figure 84: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033

Figure 85: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033

Figure 86: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 87: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 88: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033

Figure 89: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033

Figure 90: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033

Figure 91: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033

Figure 92: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033

Figure 93: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033

Figure 94: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033

Figure 95: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033

Figure 96: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033

Figure 97: Asia Pacific T-cell Therapy Market Attractiveness by Indication , 2023-2033

Figure 98: Asia Pacific T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033

Figure 99: Asia Pacific T-cell Therapy Market Attractiveness by Modality , 2023-2033

Figure 100: Asia Pacific T-cell Therapy Market Attractiveness by Country, 2023-2033

Figure 101: MEA T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033

Figure 102: MEA T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033

Figure 103: MEA T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033

Figure 104: MEA T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033

Figure 105: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033

Figure 106: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 107: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 108: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033

Figure 109: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033

Figure 110: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033

Figure 111: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033

Figure 112: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033

Figure 113: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033

Figure 114: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033

Figure 115: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033

Figure 116: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033

Figure 117: MEA T-cell Therapy Market Attractiveness by Indication , 2023-2033

Figure 118: MEA T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033

Figure 119: MEA T-cell Therapy Market Attractiveness by Modality , 2023-2033

Figure 120: MEA T-cell Therapy Market Attractiveness by Country, 2023-2033

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

510

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved